![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CTK Biotech Gains CE Mark for Onsite COVID-19 Self-Test
CTK Biotech Gains CE Mark for Onsite COVID-19 Self-Test
Poway, Calif.-based CTK Biotech has received a CE mark certification for its Onsite COVID-19 antigen self-test.
The single-use test, which can detect SARS-CoV-2 antigens in nasal swab specimens from infected individuals, is intended for use with self-collected samples within the first seven days after symptoms begin.
CTK Biotech said it will begin shipping the test this month to countries that accept the CE mark.
Upcoming Events
-
21Oct